A practical guide for OB/GYNs and providers on helping patients find and access Orilissa, including pharmacy strategies, insurance navigation, and workflow tips.
You've determined that Orilissa (Elagolix) is the right choice for your patient's endometriosis pain. The clinical decision is made — but the access journey is just beginning. For many patients, the hardest part of Orilissa isn't taking it. It's finding it.
As a specialty, brand-name medication with a cash price of $1,200–$1,700 per month, Orilissa is not routinely stocked at most retail pharmacies. Patients often encounter pharmacy stockouts, prior authorization requirements, and specialty pharmacy mandates that can delay or derail treatment.
This guide provides actionable steps you and your staff can take to smooth that process.
Orilissa is not in a formal shortage as of 2026. AbbVie continues to manufacture and distribute it. However, retail pharmacy availability remains inconsistent due to:
Understanding the patient's perspective helps you anticipate problems. Here's what patients typically experience:
Studies consistently show that access barriers for specialty medications contribute to high prescription abandonment rates. Proactive intervention at the point of prescribing can make a significant difference.
Don't wait for the pharmacy to trigger the PA process. Initiate it from your office the same day you write the prescription. Use electronic prior authorization (ePA) tools when available — they can reduce turnaround from days to hours.
Common PA criteria for Orilissa include:
Having this documentation ready before submitting the PA significantly improves approval rates.
Before sending the prescription to the patient's regular retail pharmacy, check whether their insurance plan requires a specialty pharmacy. If so, send it directly there. This avoids the frustrating back-and-forth of having the retail pharmacy reject it and the patient having to start over.
If the patient's plan doesn't require a specialty pharmacy, consider sending the prescription to a pharmacy you know stocks Orilissa. Use Medfinder for Providers to check real-time inventory at nearby pharmacies.
Cost is a major driver of prescription abandonment for Orilissa. At the time of prescribing:
Identify 1–2 specialty pharmacies that reliably stock Orilissa and work well with your practice. Benefits include:
Having a go-to specialty pharmacy eliminates the guesswork for both your staff and your patients.
Before the patient leaves, set expectations and provide resources:
This proactive communication reduces patient anxiety and keeps them in the treatment pipeline.
If access barriers prove insurmountable, consider these alternatives:
See our detailed comparison: Alternatives to Orilissa.
Prescribing Orilissa is only half the battle. Ensuring your patient can actually access it requires proactive steps at the point of care. By initiating prior authorization early, routing prescriptions to the right pharmacy, connecting patients with financial assistance, and building specialty pharmacy relationships, you can significantly reduce the access gap.
Visit Medfinder for Providers for real-time pharmacy inventory tools, and share our patient resources — like how to find Orilissa in stock — to empower patients in their own access journey.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
